VC and entrepreneurs are my favorite type of people: optimists. I am passionate about working with them knowing they play a key role in launching and shaping revolutionary companies. Both are the futurists, hand-holders, and risk-takers in the financial world.
Dongxue now leads corporate development team at GUDU MEDICAL PTE. LTD, the core enterprise of the medical devices supply chain under the umbrella of CITIC Pacific, a conglomerate directly supervised by the Chinese Ministry of Finance providing leadership in evaluating and executing new medical devices- oriented investment opportunities in urology, neurosurgery, cardiology fields to drive long-term inorganic growth. Prior to GUDU medical, Dongxue worked as a corporate venture investor at Homevalley Capital, a head of marketing at MoreHealth (Venture-backed private company in digital health sector), and an investor relations at BiopharmaX (BPMX, Dermatology & Cosmetics focused pharmaceutical company). Prior BPMX, Dongxue worked as a research assistant at Stanford medical center for stroke prevention experiments. Dongxue founded AtherPartners (AP) in 2017, a consulting firm specialized in competitive strategy serves healthcare companies cross three continents, Asia, Europe and North America. Dongxue started her career at international investment department at government of Shanghai, China.
Dongxue received her B.A. in Mass Communication/Journalism from Southwest Minzu University in China, M.S. in Social Science from University of Pennsylvania, and M.B.A from University of California, Berkeley.
LinkedIn profile: https://www.linkedin.com/in/dongxuehwang/
Twitter link: https://twitter.com/DongxueHWang